BCLI
BRAINSTORM CELL THERAPUTC
BCLI
BCLI
Delisted
BCLI was delisted on the 17th of July, 2025.
75 hedge funds and large institutions have $32.1M invested in BRAINSTORM CELL THERAPUTC in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 24 increasing their positions, 23 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
35% less call options, than puts
Call options by funds: $3.17M | Put options by funds: $4.87M
58% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 26
Holders
75
Holding in Top 10
–
Calls
$3.17M
Puts
$4.87M
Top Buyers
| 1 | +$1.58M | |
| 2 | +$1.12M | |
| 3 | +$523K | |
| 4 |
Two Sigma Advisers
New York
|
+$461K |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$384K |
Top Sellers
| 1 | -$1.04M | |
| 2 | -$674K | |
| 3 | -$579K | |
| 4 |
PF
Phoenix Financial
Givatayim,
Israel
|
-$440K |
| 5 |
OQS
Occudo Quantitative Strategies
Fort Lauderdale,
Florida
|
-$410K |